Allergan plc announced that it has received an Imported Drugs License (IDL) from the Chinese FDA to market Ozurdex® (dexamethasone...
Read moreEisai Co., Ltd. and Biogen Inc. announced that the companies have expanded their existing agreement to jointly develop and commercialize...
Read moreViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results...
Read more
Servier and GeNeuro announced post hoc analyses of 6-month data from the CHANGE-MS Phase 2b study of GNbAC1 for the...
Read more
Eagle Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s...
Read moreSun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has received final approval from US FDA for...
Read moreRoche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in...
Read moreAbbVie , a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.announced that the U.S. FDA...
Read moreAllergan plc presented new analyses of VENUS II, the second of two pivotal Phase 3 clinical trials evaluating the efficacy...
Read moreIn this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
